14th June 2011
One in five deaths in the year following a heart attack could be prevented with the use of a new drug, a scientist at the University of Sheffield has claimed.
Professor Robert Storey, professor of cardiology in the department of cardiovascular research, has led several investigations into the effects of ticagrelor and concluded throughout that it was more effective than the current treatment clopidogrel in reducing death and recurrent heart attack.
The drug was made available in the UK last December, but it has not yet been adopted across most of the country because of cost concerns. However, advocates believe that the increased effectiveness of the drug makes up for the extra expense.
Professor Storey said: "Many people are dying avoidably in the year after having a heart attack due to delays introducing this new treatment. These new findings provide yet further evidence in support of making the drug available to patients in the UK."
Heart attacks are the leading cause of death for both men and women in all parts of the world.
Posted by Edward Bartel
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.